Keywords: A; adenine; A549; adenocarcinomic human alveolar basal epithelial cells; AKR1C3; Aldo_Keto Reductase; BaP; Benzo(a)pyrene; C; cytosine; CI; Confidence interval; CO; carbon monoxide; CXCL 13; motif chemokine ligand 13; CYP1B1; cytochrome P450 1B1; DKK2; Di
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Endometrium; Androgen receptor (AR); Decidualisation; Proliferation; Testosterone (T); Dihydrotestosterone (DHT); AKR1C3; SRD5A1; Scarless healing; Endometriosis; Cancer;
AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling
Keywords: Prostate cancer; Metastasis; Epithelial-to-mesenchymal transition; AKR1C3; ERK; Transcription factor;
Drug-DNA adducts as biomarkers for metabolic activation of the nitro-aromatic nitrogen mustard prodrug PR-104A
Keywords: PR-104A; DNA adducts; Predictive biomarkers; AKR1C3; P450 oxidoreductase;
Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C19 steroids as the predominant androgens in prostate cancer
Keywords: UDP; uridine diphosphate; UGT; UDP-glucuronosyltransferases; 17βHSD; 17β-hydroxysteroid dehydrogenase; AKR1C3; 17β-hydroxysteroid dehydrogenase type 5; 11βHSD2; 11β-hydroxysteroid dehydrogenase type 2; SRD5A; 5α-reductase; SRD5A1; 5α-reductase type
Novel SNPs of WNK1 and AKR1C3 are associated with preeclampsia
Keywords: WNK1; lysine deficient protein kinase 1; ADRB2; β2 adrenergic receptor; NEDD4L; ubiquitin-protein ligase NEDD4-like; KLK1; kallikrein 1; AKR1C3; aldo-keto reductase family1 member C3; SNPs; single nucleotide polymorphisms; CI; confidence interval; OR; od
Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
Keywords: AKR; aldo-keto reductase; CDK; cyclin-dependent kinase; CI; combination index; Dau; daunorubicin; Dau-ol; daunorubicinol; DOX; doxorubicin; DMSO; dimethyl sulfoxide; Fa; fraction affected; HCT116-AKR1C3; cells transfected with pCI_AKR1C3; HCT116-EV; cells
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
Keywords: Aldo-keto reductase 1C3; AKR1C3; 17β-HSD5; Prostate cancer (PCa); CRPC; Bioisosterism; Scaffold hopping; Inhibitors; X-ray crystallography;
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach
Keywords: Aldo-keto reductase 1C3; AKR1C3; 17β-HSD5; Prostate cancer; CRPC; Bioisosterism; Scaffold hopping; Inhibitors; NWCHXFMRNUJDNB-UHFFFAOYSA-N; HZZCFCAKQYBGLE-UHFFFAOYSA-N; YQJHRNZFIOVGQM-UHFFFAOYSA-N; UHUYUGANTDDPEB-UHFFFAOYSA-N; DWGCYTWMYJCZRX-UHFFFAOYSA-N
Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells
Keywords: Prostate cancer; 17B-Hydroxysteroid dehydrogenase; AKR1C3; PPAR; Prostaglandins; Bezafibrate
Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN Loss
Keywords: AKR1C3; Human breast cancer; DOX resistance; PTEN loss; PTEN/Akt
Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model
Keywords: Nrf2/ARE activators; Oxime-bearing coumarins; Antioxidant activity; Cytoprotection; ABCC3; ATP-binding cassette, subfamily C, member 1; AKR1C1; aldo-keto reductase 1 subunit C-1; AKR1C2; aldo-keto reductase 1 subunit C-2; AKR1C3; aldo-keto reductase 1 sub
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro
Keywords: DHEA; dehydroepiandrosterone; DHT; dihydrotestosterone; LHRH; luteinizing hormone releasing hormone; LH; luteinizing hormone; AR; androgen receptor; CRPC; castration resistant prostate cancer; PSA; prostate specific antigen; SRD5A1/2; 5-alpha-reductase is
Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors
Keywords: Adion; 4-androstene-3,17-dione; DHO; dihydrooracin; DHO assay; reduction of oracin to DHO assay; DMSO; dimethyl sulfoxide; HPLC; high-performance liquid chromatography; MTT; 3-(4,5-dimethylthiazoyl-2-yl)2,5diphenyl tetrazolium bromide; NADPH; nicotinamide
Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C3
Keywords: AKR1A1; aldo-keto reductase 1A1; AKR1B1; aldo-keto reductase 1B1; AKR1B10; aldo-keto reductase 1B10; AKR1C3; aldo-keto reductase 1C3; CBR1; carbonyl reductase 1; qRT-PCR; quantitative real-time reverse transcription PCR; UHPLC; ultra-high performance liqu
Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity
Keywords: Isoquinoline; Triazole; Pictet-Spengler reaction; Antiproliferative activity; Molecular docking; AKR1C3;
Identification of proteomic signatures associated with lung cancer and COPD
Keywords: 2D-PAGE; Two dimensional electrophoresis; AKR1B10; Aldo-keto reductase family 1, member B10; AKR1C3; Aldo-keto reductase family 1, member C3; ALDH3A1; Aldehyde dehydrogenase 3 family, member A1; ALDOA; Aldolase A; AMY1A; Alpha 1 amylase; AMY2A; Alpha 2 am
11β-Hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione
Keywords: 11KA4; 11-ketoandrostenedione; 11KT; 11-ketotestosterone; 11OH-5α-dione; 11β-hydroxy 5α-androstanedione; 11OH-AST; 11β-hydroxyandrosterone; 11OHA4; 11β-hydroxyandrostenedione; 11OHT; 11β-hydroxytestosterone; 11βHSD; 11β-hydroxysteroid dehydrogenas
2,3-Diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17β-hydroxysteroid dehydrogenase (AKR1C3)
Keywords: Aldo-keto reductase; AKR1C3; Selective inhibitors; 2,3-Diarylpropenoic acids; CancerDMF, N,N-dimethylformamide; DMSO, dimethyl sulfoxide; ESI, electrospray ionization; HPLC, high-performance liquid chromatography; HRMS, high-resolution mass spectrometry;
Polymorphisms in androgen signaling pathway predisposing to prostate cancer
Keywords: AKR1C3; 3α-hydroxysteroid dehydrogenase; AR; androgen receptor; CNV; copy number variation; CYP; cytochrome P450; DHEA; dehydroepiandrosterone; DHT; dehydrotestosterone; HSD17B; 17β-hydroxysteroid dehydrogenase; HSD3B; hydroxy-δ-5-steroid dehydrogenase
Cadmium-induced up-regulation of aldo-keto reductase 1C3 expression in human nasal septum carcinoma RPMI-2650 cells: Involvement of reactive oxygen species and phosphatidylinositol 3-kinase/Akt
Keywords: Cadmium; AKR1C3; RPMI-2650 cells; ROS; PI3K/Akt;
Estrogen biosynthesis in human H295 adrenocortical carcinoma cells
Keywords: Human adrenocortical H295 cells; Estrogen biosynthesis; Aromatase; CYP19; 17β-Hydroxysteroid dehydrogenase type 5; AKR1C3; Human adrenal cortex;
Disturbed estrogen and progesterone action in ovarian endometriosis
Keywords: Endometriosis; 17β-Hydroxysteroid dehydrogenases; AKR1C1; AKR1C3; Estrogen- and progesterone-metabolizing enzymes; Estrogen and progesterone receptors
Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues
Keywords: DOC; Mineralocorticoid; Inactivation; AKR1C3; Human; Kidney; Colon
Paracrine-stimulated gene expression profile favors estradiol production in breast tumors
Keywords: AKR1C3; Aromatase; Estrogen; Breast cancer; Breast adipose fibroblast; Epithelial–stromal interaction
Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer
Keywords: Green tea; Smoky coal; Lung cancer; OGG1; AKR1C3; GSTM1;